Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    IgA nephropathy recurrence after living donor kidney transplantation: a retrospective analysis of postoperative outcomes at a single high-volume transplant center

    IgA nephropathy (IgAN) is a common primary glomerulonephritis leading to end-stage renal disease. Living donor kidney transplantation (LDKT) is considered a favorable treatment option, but IgAN recurrence rate...

    Jacob Schmidt, Lutz Liefeldt, Emre Baysal, Stella Töpfer in Renal Replacement Therapy (2024)

  2. No Access

    Article

    Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience

    To evaluate the long-term oncological outcomes and functional results of the neurovascular structure-adjacent frozen-section examination (NeuroSAFE) during nerve-sparing (NS) radical prostatectomy (RP).

    Francesca Ambrosini, Felix Preisser, Derya Tilki in Prostate Cancer and Prostatic Diseases (2024)

  3. Article

    Open Access

    PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors

    A high level of PD-L1 expression is the most relevant predictive parameter for response to immune checkpoint inhibitor (CPI) therapy in urinary bladder cancer. Existing data on the relationship between PD-L1 e...

    Henning Plage, Kira Furlano, Sebastian Hofbauer, Sarah Weinberger in BMC Urology (2024)

  4. Article

    Open Access

    Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder

    Uroplakin-1a (Upk1a) and uroplakin-1b (Upk1b) have recently been identified as diagnostic markers for the distinction of urothelial carcinomas from other solid tumor entities. Both proteins play an important r...

    Krystian Kaczmarek, Henning Plage, Kira Furlano in International Urology and Nephrology (2024)

  5. No Access

    Article

    Zielgerichtete Therapieoptionen in der Uroonkologie

    Fortschritte im molekulargenetischen Verständnis uroonkologischer Tumorerkrankungen ermöglichen die Identifikation zahlreicher neuer therapeutischer Zielstrukturen. Auf Grundlage routinemäßig anwendbarer Tumor...

    Antonia Franz, Henning Plage, Annika Fendler, Thorsten Schlomm in best practice onkologie (2023)

  6. No Access

    Article

    Zielgerichtete Therapieoptionen in der Uroonkologie

    Fortschritte im molekulargenetischen Verständnis uroonkologischer Tumorerkrankungen ermöglichen die Identifikation zahlreicher neuer therapeutischer Zielstrukturen. Auf Grundlage routinemäßig anwendbarer Tumor...

    Antonia Franz, Henning Plage, Annika Fendler, Thorsten Schlomm in Die Urologie (2023)

  7. No Access

    Article

    Transurethral suturing of bladder following transurethral excision of female vesico-urachal diverticula: a novel technique with long-term follow-up results

    This study aims to describe and evaluate outcomes of transurethral surgery-natural orifice transluminal endoscopic surgery (TUS-Notes) technique in patients treated with transurethral excision of vesico-urach...

    Joerg Neymeyer, Alkan Çubuk, Isabella Marina Handke in Clinical and Experimental Nephrology (2022)

  8. Article

    Open Access

    Follow-up of men with a PI-RADS 4/5 lesion after negative MRI/Ultrasound fusion biopsy

    Magnetic resonance imaging/Ultrasound (MRI/US) fusion targeted biopsy (TB) in combination with a systematic biopsy (SB) improves cancer detection but limited data is available how to manage patients with a Prosta...

    Kira Kornienko, Miriam Reuter, Andreas Maxeiner, Karsten Günzel in Scientific Reports (2022)

  9. Article

    Open Access

    Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer

    Epithelial splicing regulatory protein 1 (ESRP1) and 2 (ESRP2) regulate alternative splicing events of various pre-mRNAs. Some of these targets play a role in cancer-associated processes, including cytoskeleto...

    Morton Freytag, Martina Kluth, Elena Bady, Claudia Hube-Magg in BMC Cancer (2020)

  10. Article

    Open Access

    EGFR as a stable marker of prostate cancer dissemination to bones

    Prostate cancer (PCa) is among the most commonly diagnosed malignancies in men. Although 5-year survival in patients with localised disease reaches nearly 100%, metastatic disease still remains incurable. Ther...

    Paulina Nastały, Sara Stoupiec, Marta Popęda, Julia Smentoch in British Journal of Cancer (2020)

  11. Article

    Open Access

    Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

    Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) is a ubiquitous RNA splicing factor that is overexpressed and prognostically relevant in various human cancer types. To study the impact of hnRNPA1 expressi...

    Katharina Möller, Anna Lena Wecker, Doris Höflmayer, Christoph Fraune in Virchows Archiv (2020)

  12. Article

    Open Access

    Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions

    Secreted frizzled-related protein 4 (SFRP4) controls WNT signaling and is thought to play a role for tumor aggressiveness. Here, we analyzed a tissue microarray containing 11,152 prostate cancers with patholog...

    Christian Bernreuther, Ferdous Daghigh, Katharina Möller in Pathology & Oncology Research (2020)

  13. No Access

    Article

    Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

    Claudin-1 is a membrane-tight junction protein and important for the sealing of the paracellular cleft in epithelial and endothelial cells. Differential expression of Claudin-1 is linked to disease outcome in ...

    Simon Kind, Franziska Büscheck, Doris Höflmayer in World Journal of Urology (2020)

  14. Article

    Open Access

    A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy

    A pre-specified model based on four kallikrein markers in blood, commercially available as 4Kscore, predicts Gleason Grade (GG) 3 + 4 or higher prostate cancer on biopsy. However, sampling error and variation ...

    Alexander Haese, Amy L. Tin, Sigrid V. Carlsson in British Journal of Cancer (2020)

  15. No Access

    Article

    The gordian knots

    Thorsten Schlomm in World Journal of Urology (2020)

  16. Article

    Open Access

    Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

    The transcriptional coactivator YAP1 controls the balance between cell proliferation and apoptosis. YAP1 overexpression is linked to poor prognosis in many cancer types, yet its role in prostate cancer is unkn...

    Andreas Marx, Aljoscha Schumann, Doris Höflmayer, Elena Bady in Scientific Reports (2020)

  17. Article

    Open Access

    Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

    TFAP2D is a transcription factor important for modulating gene expression in embryogenesis. Its expression and prognostic role in prostate cancer has not been evaluated.

    Christoph Fraune, Luisa Harms, Franziska Büscheck, Doris Höflmayer in Molecular Medicine (2020)

  18. Article

    Open Access

    Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy

    Accurate risk stratification can help guide appropriate treatment decisions in men with localized prostate cancer. Here, we evaluated the independent ability of the molecular cell cycle progression (CCP) score...

    Daniel J. Canter, Stephen Freedland in Prostate Cancer and Prostatic Diseases (2020)

  19. Article

    Open Access

    Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer

    The role of subcellular survivin compartmentalization in the biology and prognosis of prostate cancer is unclear. We therefore investigated subcellular localization of survivin in more than 3000 prostate cance...

    Jan K. Hennigs, Sarah Minner, Pierre Tennstedt, Rolf Löser in Scientific Reports (2020)

  20. No Access

    Living Reference Work Entry In depth

    Therapie bei isoliertem PSA-Anstieg

    Der isolierte PSA-Anstieg nach initialer Strahlentherapie besitzt einen besonderen Stellenwert im urologischen Alltag. Nicht nur die Definition des Rezidivs, sondern auch dessen Diagnostik ist mit einigen Beso...

    Felix Preisser, Markus Graefen, Jens Hansen, Patrick J. Bastian in Uroonkologie

previous disabled Page of 3